Search Results - "Wight, T N"

Refine Results
  1. 1

    Tissue integrity signals communicated by high-molecular weight hyaluronan and the resolution of inflammation by Ruppert, S. M., Hawn, T. R., Arrigoni, A., Wight, T. N., Bollyky, P. L.

    Published in Immunologic research (01-05-2014)
    “…The extracellular matrix polysaccharide hyaluronan (HA) exerts size-dependent effects on leukocyte behavior. Low-molecular weight HA is abundant at sites of…”
    Get full text
    Journal Article
  2. 2

    Heparan Sulfate in Perlecan Promotes Mouse Atherosclerosis: Roles in Lipid Permeability, Lipid Retention, and Smooth Muscle Cell Proliferation by Tran-Lundmark, Karin, Tran, Phan-Kiet, Paulsson-Berne, Gabrielle, Fridén, Vincent, Soininen, Raija, Tryggvason, Karl, Wight, Thomas N, Kinsella, Michael G, Borén, Jan, Hedin, Ulf

    Published in Circulation research (03-07-2008)
    “…Heparan sulfate (HS) has been proposed to be antiatherogenic through inhibition of lipoprotein retention, inflammation, and smooth muscle cell proliferation…”
    Get full text
    Journal Article
  3. 3

    Formation of Hyaluronan- and Versican-Rich Pericellular Matrix Is Required for Proliferation and Migration of Vascular Smooth Muscle Cells by Evanko, Stephen P, Angello, John C, Wight, Thomas N

    “…The accumulation of hyaluronan (HA) and the HA-binding proteoglycan versican around smooth muscle cells in lesions of atherosclerosis suggests that together…”
    Get full text
    Journal Article
  4. 4

    Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and the proximity of platelet-derived growth factor and transforming growth factor-beta by Evanko, SP, Raines, EW, Ross, R, Gold, LI, Wight, TN

    Published in The American journal of pathology (01-02-1998)
    “…The accumulation of proteoglycans (PGs) in atherosclerosis contributes to disease progression and stenosis and may partly depend on local regulation by growth…”
    Get full text
    Journal Article
  5. 5

    Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans by Nakashima, Yutaka, Wight, Thomas N., Sueishi, Katsuo

    Published in Cardiovascular research (01-07-2008)
    “…This review attempts to define the early events that lead to lesions of human atherosclerosis based on careful morphological studies in human autopsy…”
    Get full text
    Journal Article
  6. 6

    Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding by Borén, J, Olin, K, Lee, I, Chait, A, Wight, T N, Innerarity, T L

    Published in The Journal of clinical investigation (15-06-1998)
    “…The subendothelial retention of LDLs through their interaction with proteoglycans has been proposed to be a key process in the pathogenesis of atherosclerosis…”
    Get full text
    Journal Article
  7. 7

    Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques : Colocalization of biglycan with apolipoproteins by O'BRIEN, K. D, OLIN, K. L, ALPERS, C. E, CHIU, W, FERGUSON, M, HUDKINS, K, WIGHT, T. N, CHAIT, A

    Published in Circulation (New York, N.Y.) (11-08-1998)
    “…Because the content of specific proteoglycans and apolipoproteins is increased in atherosclerotic plaques and in vitro studies have suggested a role for…”
    Get full text
    Journal Article
  8. 8

    The Sulfate Moieties of Glycosaminoglycans Are Critical for the Enhancement of β‐Amyloid Protein Fibril Formation by Castillo, Gerardo M., Lukito, Widia, Wight, Thomas N., Snow, Alan D.

    Published in Journal of neurochemistry (01-04-1999)
    “…: Our previous studies have demonstrated that perlecan and perlecan‐derived glycosaminoglycans (GAGs) not only bind β‐amyloid protein (Aβ) 1‐40 and 1‐42, but…”
    Get full text
    Journal Article
  9. 9

    Perlecan Binds to the β‐Amyloid Proteins (Aβ) of Alzheimer's Disease, Accelerates Aβ Fibril Formation, and Maintains Aβ Fibril Stability by Castillo, Gerardo M., Ngo, Catherine, Cummings, Joel, Wight, Thomas N., Snow, Alan D.

    Published in Journal of neurochemistry (01-12-1997)
    “…: Perlecan is a specific heparan sulfate proteoglycan that accumulates in the fibrillar β‐amyloid (Aβ) deposits of Alzheimer's disease. Perlecan purified from…”
    Get full text
    Journal Article
  10. 10

    Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries by Riessen, R, Isner, JM, Blessing, E, Loushin, C, Nikol, S, Wight, TN

    Published in The American journal of pathology (01-05-1994)
    “…Proteoglycans are important constituents of blood vessels and accumulate in various forms of vascular disease. Little is known concerning the proteoglycan…”
    Get full text
    Journal Article
  11. 11

    Platelet-Derived Growth Factor Stimulates the Formation of Versican–Hyaluronan Aggregates and Pericellular Matrix Expansion in Arterial Smooth Muscle Cells by Evanko, Stephen P., Johnson, Pamela Y., Braun, Kathleen R., Underhill, Charles B., Dudhia, Jayesh, Wight, Thomas N.

    Published in Archives of biochemistry and biophysics (01-10-2001)
    “…Hyaluronan and versican-rich pericellular matrices form around arterial smooth muscle cells (ASMC) preferentially during the detachment phase of proliferation…”
    Get full text
    Journal Article
  12. 12

    Smooth muscle cell expression of extracellular matrix genes after arterial injury by Nikkari, ST, Jarvelainen, HT, Wight, TN, Ferguson, M, Clowes, AW

    Published in The American journal of pathology (01-06-1994)
    “…Accumulation of extracellular matrix (ECM) after arterial injury is an important event in the development of intimal thickening and is modulated by heparin. To…”
    Get full text
    Journal Article
  13. 13
  14. 14

    The pharmacokinetics and dosing of oral 4‐methylumbelliferone for inhibition of hyaluronan synthesis in mice by Kuipers, H. F., Nagy, N., Ruppert, S. M., Sunkari, V. G., Marshall, P. L., Gebe, J. A., Ishak, H. D., Keswani, S. G., Bollyky, J., Frymoyer, A. R., Wight, T. N., Steinman, L., Bollyky, P. L.

    Published in Clinical and experimental immunology (01-09-2016)
    “…Summary Recently, there has been considerable interest in using 4‐methylumbelliferone (4‐MU) to inhibit hyaluronan (HA) synthesis in mouse models of cancer,…”
    Get full text
    Journal Article
  15. 15

    Fenofibrate modifies human vascular smooth muscle proteoglycans and reduces lipoprotein binding by NIGRO, J, BALLINGER, M. L, DILLEY, R. J, JENNINGS, G. L. R, WIGHT, T. N, LITTLE, P. J

    Published in Diabetologia (01-12-2004)
    “…Vascular disease in type 2 diabetes is associated with an up-regulation of atherogenic growth factors, which stimulate matrix synthesis including…”
    Get full text
    Journal Article
  16. 16

    Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients: clinical, immunocytochemical. light and electron microscopic assessment by SWEDBERG, S. H, BROWN, B. G, SIGLEY, R, WIGHT, T. N, GORDON, D, NICHOLLS, S. C

    Published in Circulation (New York, N.Y.) (01-12-1989)
    “…Failure of arteriovenous communications used for chronic hemodialysis was studied during sequential 5-year periods after placement of either endogenous…”
    Get full text
    Journal Article
  17. 17

    Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries by Wight, TN, Lara, S, Riessen, R, Le Baron, R, Isner, J

    Published in The American journal of pathology (01-10-1997)
    “…Although a large percentage of the volume of human restenotic arterial lesions is occupied by extracellular matrix (ECM), the composition and organization of…”
    Get full text
    Journal Article
  18. 18

    The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease by Snow, AD, Mar, H, Nochlin, D, Kimata, K, Kato, M, Suzuki, S, Hassell, J, Wight, TN

    Published in The American journal of pathology (01-12-1988)
    “…Two immunocytochemical probes were used to specifically identify and localize heparan sulphate proteoglycans (HSPGs) in 17 cases of Alzheimer's disease (AD). A…”
    Get full text
    Journal Article
  19. 19

    Early accumulation of heparan sulfate in neurons and in the beta- amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome by Snow, AD, Mar, H, Nochlin, D, Sekiguchi, RT, Kimata, K, Koike, Y, Wight, TN

    Published in The American journal of pathology (01-11-1990)
    “…A monoclonal antibody (HK-249) that recognizes a glucosamine sulfate alpha 1---4 glucuronic acid-containing determinant in heparan sulfate (HS) chains of a…”
    Get full text
    Journal Article
  20. 20

    Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells by Schönherr, E., Järveläinen, H.T., Sandell, L.J., Wight, T.N.

    Published in The Journal of biological chemistry (15-09-1991)
    “…Platelet-derived growth factor (PDGF) and transforming growth factor-beta 1 (TGF-beta 1) increase [35S]sulfate incorporation into proteoglycan (PG) by monkey…”
    Get full text
    Journal Article